Tracon Pharmaceuticals, Inc.
TCONDelisted Jul 19, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001394319
Tracon Pharmaceuticals, Inc. was delisted on Jul 19, 2024; its insiders filed their last Form 4 on Mar 13, 2024; 29 institutions reported holding it in 13F filings for Q1 2024, worth $1.39M in total; no superinvestor held it.
Q4 2022 vs. Q3 2022
How the institutions holding Tracon Pharmaceuticals, Inc. changed between Q3 2022 and Q4 2022.
All holders in Q4 2022All holders in Q3 2022
| Measure | Q3 2022 | Of which not filed for Q4 2022 | Q4 2022 | Change |
|---|---|---|---|---|
| Holders | 33 | 2 | 32 | +1 |
| Shares | 9.86M | 76.0K | 9.82M | +36.9K (+0.4%) |
| Value | $16.5M | $127.0K | $14.6M | −$1.70M (−10.4%) |
2 institutions that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (7)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q4 2022 but not at the end of Q3 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CI Private Wealth, LLC | 57,455 | $85.6K | 0.00% |
| Virtu Financial LLC | 45,279 | $67.0K | 0.01% |
| Coastal Bridge Advisors, LLC | 10,000 | $14.9K | 0.00% |
| Advisory Services Network, LLC | 2,000 | $2.98K | 0.00% |
| ICA Group Wealth Management, LLC | 100 | $168 | 0.00% |
| Bank of America Corp | 46 | $68 | 0.00% |
| Morgan Stanley | 7 | $10 | 0.00% |
Sold out (6)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q3 2022 and filed for Q4 2022 without it.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| NEA Management Company, LLC | 346,719 | $579.0K |
| CSS LLC | 45,219 | $76.0K |
| Two Sigma Investments, LP | 40,179 | $67.0K |
| Millennium Management LLC | 34,390 | $57.0K |
| Susquehanna International Group, LLP | 12,919 | $22.0K |
| Royal Bank of Canada | 22 | $0 |
Not filed for Q4 2022 yet (2)
Institutions that held Tracon Pharmaceuticals, Inc. at the end of Q3 2022 and haven't filed a 13F for Q4 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q3 2022 | Value, Q3 2022 |
|---|---|---|
| Dowling & Yahnke LLC | 47,455 | $79.0K |
| ACT Capital Management, LLC | 28,500 | $48.0K |